ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm
2008

ETS-1 and ETS-2 in Ocular Tumors

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): De la Houssaye G., Vieira V., Masson C., Beermann F., Dufier J.L., Menasche M., Abitbol M.

Primary Institution: Université Paris-Descartes

Hypothesis

The study investigates the role of ETS-1 and ETS-2 in a transgenic mouse model of pigmented ocular neoplasm.

Conclusion

ETS-1 and ETS-2 are upregulated in ocular tumors derived from the retinal epithelium and may be involved in signaling pathways that activate genes related to tumor progression.

Supporting Evidence

  • ETS-1 and ETS-2 mRNA and protein levels were much higher in the ocular tissues of Tyrp-1-TAg mice than in control ocular tissues.
  • The upregulation of ETS-1 and ETS-2 was correlated with tumor progression.
  • Both ETS-1 and ETS-2 were detected in various ocular cell types.

Takeaway

The study found that two proteins, ETS-1 and ETS-2, are more active in eye tumors in mice, which might help us understand how these tumors grow.

Methodology

The study used in situ hybridization, immunohistochemistry, semi-quantitative RT-PCR, and western blotting to analyze the expression of ETS-1 and ETS-2 in mouse ocular tissues.

Limitations

The study is based on a specific transgenic mouse model and may not fully represent human ocular tumors.

Participant Demographics

Transgenic CB6 Tyrp-1-TAg mice and normal CB6 mice were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication